POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER

乳腺癌抗基因疗法中的多胺类似物

基本信息

  • 批准号:
    6443430
  • 负责人:
  • 金额:
    $ 1.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-06-01 至 2005-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (As Adapted From the Investigator's Abstract): The long-term goal for this project is to develop a triplex DNA-based anti-gene strategy for breast cancer treatment. The applicant's studies during the previous funding period have demonstrated a remarkable structural specificity effect of polyamine analogs in stabilizing triplex DNA, and in facilitating the uptake of a triplex forming oligonucleotide (TFO) in breast cancer cells. Their hypothesis is that the selective utilization of polyamine analogs is a viable strategy to increase the stability of triplex DNA, and enhance the therapeutic potential of TFOs. This hypothesis will be tested by: 1) Quantification of the ability of novel polyamine analogs to stabilize triplex DNA at the promoter site sequences of cmyc, her2, and cyclinD1 genes by spectroscopic techniques, fluorescence measurements, and electrophoretic mobility shift assay; 2) elucidation of the role of polyamine -induced TFO condensation in facilitating nuclear uptake of TFOs and determination of TFO accumulation and stability in breast cancer cells; 3) Evaluation of the biologic response of TFOs and polyamine analogs as single agents and in combination on breast cancer cells by Northern and Western blot analysis of target gene expression, and polyamine metabolism pathways; and 4) Elucidation of the mechanism of TFO/polyamine analog action in terms of transcription factors to targeted sites. Results of these studies will help to develop a new therapeutic modality for breast cancer, and advance our knowledge of the mechanism of triplex DNA stabilization in vitro.
描述(根据研究者摘要改编):长期目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TJ THOMAS其他文献

TJ THOMAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TJ THOMAS', 18)}}的其他基金

Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
  • 批准号:
    7939375
  • 财政年份:
    2009
  • 资助金额:
    $ 1.43万
  • 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
  • 批准号:
    6633220
  • 财政年份:
    2000
  • 资助金额:
    $ 1.43万
  • 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
  • 批准号:
    6376346
  • 财政年份:
    2000
  • 资助金额:
    $ 1.43万
  • 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
  • 批准号:
    6748436
  • 财政年份:
    2000
  • 资助金额:
    $ 1.43万
  • 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
  • 批准号:
    6449297
  • 财政年份:
    2000
  • 资助金额:
    $ 1.43万
  • 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
  • 批准号:
    6513053
  • 财政年份:
    2000
  • 资助金额:
    $ 1.43万
  • 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
  • 批准号:
    6200101
  • 财政年份:
    2000
  • 资助金额:
    $ 1.43万
  • 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
  • 批准号:
    6630988
  • 财政年份:
    1999
  • 资助金额:
    $ 1.43万
  • 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
  • 批准号:
    6889575
  • 财政年份:
    1999
  • 资助金额:
    $ 1.43万
  • 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
  • 批准号:
    7034171
  • 财政年份:
    1999
  • 资助金额:
    $ 1.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了